Aristotle Capital Boston LLC 13D and 13G filings for CAMP4 Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-10 4:39 pm Sale | 2023-09-30 | 13G | CAMP4 Therapeutics Corporation CAMP | Aristotle Capital Boston LLC | 0 0.000% | -115,250 (Position Closed) | Filing |
| 2023-02-14 09:00 am Sale | 2022-12-31 | 13G | CAMP4 Therapeutics Corporation CAMP | Aristotle Capital Boston LLC | 115,250 7.170% | -6,724 (-5.51%) | Filing |
| 2022-02-14 09:54 am Sale | 2021-12-31 | 13G | CAMP4 Therapeutics Corporation CAMP | Aristotle Capital Boston LLC | 121,973 7.810% | -1,992 (-1.61%) | Filing |
| 2021-02-02 1:03 pm Purchase | 2020-12-31 | 13G | CAMP4 Therapeutics Corporation CAMP | Aristotle Capital Boston LLC | 123,965 8.140% | 22,511 (+22.19%) | Filing |
| 2020-02-14 09:39 am Purchase | 2019-12-31 | 13G | CAMP4 Therapeutics Corporation CAMP | Aristotle Capital Boston LLC | 101,454 6.830% | 101,454 (New Position) | Filing |